Ratings
0
Nobody has rated this yet. Be the first!
Works
3
BET bromodomain inhibition as a therapeutic strategy to target c-Myc
Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.
The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset